BA
Insider
Bobak R. Azamian
President/CEO and Board ChairBobak R. Azamian (President/CEO and Board Chair) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales, 1 filed past the two-business-day deadline), most often in Tarsus Pharmaceuticals, Inc. (TARS). The largest single filing was $2.4M of TARS (34,603 sh across 3 lots, as filed), executed Mar 17.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
6
0 buys · 6 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.1M
shares × price, as filed
Last traded
Sep 4
Filed Sep 9
Median ADV $68.4M across their filed names
Open performance→Volume by month
Buys $0
Sells $7.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
6 filings
Sector per market data · by filing · past 12 months
Most traded names
TARSRecent filings
TARSSALE
Tarsus Pharmaceuticals, Inc.
View filing →
$1.2M24,216 sh across 3 lots
Exec Mar 18 2025
Filed Mar 20 2025 · 5:30 PM ET